Yıl: 2023 Cilt: 28 Sayı: 2 Sayfa Aralığı: 291 - 295 Metin Dili: İngilizce DOI: 10.5505/ejm.2023.76743 İndeks Tarihi: 06-06-2023

Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity

Öz:
Toxoplasma gondii (T. gondii) is an opportunistic parasite. Transmission from T. gondii-infected donors to recipients is possible through blood and organ transplantation. In this study, it was aimed to investigate the presen ce of T. gondii antibodies in healthy donors and in blood recipients with immunosuppressed hematological malignancies. A total of 92 patients included in the present study (46 donors and 46 patients). Sixteen of the hematological patients had lymphoblastic leukemia and 14 had acute myeloblastic leukemia. The presence of IgG and IgM Toxoplasma antibodies and IgG avidity values were investigated by ELISA. Twenty-two (47.8%) of patients and 11 (23.9%) of the donors were found to be positive for T.gondii IgG antibodies. IgG positivity was detected in all patient groups except those with aplastic anemia. The highest IgG positivity was found in acute myeloblastic leukemia (8) and lymphoblastic leukemia (5). IgM seropositivity was detected totally three cases (3.3%), two of 46 patients (4.3%) and one 46 of donors (2.2%). Although the number was low, all patients with chronic myeloid leukemia were detected both IgG and IgM positive (100%). Low avidity was found in all three of the IgM positive cases. Considering that toxoplasmosis is an infection that causes severe clinical symptoms and death, routine diagnostic methods that detect the presence of parasites in donor and patient groups will be beneficial for the prevention of T.gondii transmission.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Dubey, JP. Toxoplasmosis of animals and humans. 2nd. ed, Boca Raton: CRC Press 2010; 1-313.
  • 2. Khademvatan S, Saki J, Yousefi E, et al. Detection and genotyping of Toxoplasma gondii strains isolated from birds in the southwest of Iran. Br Poult Sci 2013; 54: 76– 80.
  • 3. Robert-Gangneus F, Sterkers Y, Year H, et al. Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study. J Clin Microbiol 2015; 53: 1677–1684.
  • 4. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Animal health res rev 2005; 6: 41–61.
  • 5. Kolören Z, Dubey JP. A review of toxoplasmosis in humans and animals in Turkey. Parasitol 2020; 147: 12–28.
  • 6. Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol 2013; 114: 125–145.
  • 7. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965–1976.
  • 8. Hoseini SA, Dehgani N, Sharif M, et al. Serological survey of toxoplasmosis in pregnant women. J Mazand Univ Med Sci 2014; 24(114): 146–150.
  • 9. Ahmadpour E, DaryaniA, Sharif M, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta- analysis. J Infect Dev Ctries 2014; 8: 1503– 1510.
  • 10. Beder D, Esenkaya Taşbent F. Genel özellikleri ve laboratuvar tanısı ile Toxoplasma gondii enfeksiyonları. General features and laboratory diagnosis of Toxoplasma gondii ınfection. Türkiye Parazitol Derg 2020; 44(2): 94–101.
  • 11. Varlı C, Türköz İ, Aydemir S, et al. Toksoplazmoz. Okmeydanı Tıp Derg 2016; 32: 24–28.
  • 12. Filisetti D, Candolfi E. Immune response to Toxoplasma gondii. Ann Ist Super Sanita 2004; 40: 71–80.
  • 13. Elhence P, Agarwal P, Prasad KN, et al. Seroprevalence of Toxoplasma gondii antibodies in north Indian blood donors: implications for transfusion transmissible toxoplasmosis. Transfus Apher Sci 2010; 43: 37–40.
  • 14. Bhopale GM. Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 2003; 26(4): 213–222.
  • 15. Karimi G, Mardani A, Zadsar M. Prevalence of Toxoplasma gondii among Iranian blood donors: a narrative review article. Iran J Parasitol 2016; 11(1): 10–18.
  • 16. Foroutan-Rad M, Majidiani H, Dalvand S, et al. Toxoplasmosis in blood donors: A systematic review and meta-analysis. Transf Med Rev 2016, 30(3): 116–122.
  • 17. Wang T, Han H, Pan Z, et al. Seroprevalence of Toxoplasma gondii infection in blood donors in mainland China: a systematic review and meta-analysis. Parasite 2018; 25–36.
  • 18. Ali Mİ, Abd El Wahab WM, et al. Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level. Journal of Parasitic Dis 2019; 43: 464–471.
  • 19. Hosseini SA, Golchin E, Sharif M, et al. A serological investigation and genotyping of Toxoplasma gondii among Iranian blood donors indicates threat to health of blood recipients. Transf Apher Sci 2020; 59(3): 102723.
  • 20. Yazar S, Eser B, Yay M. Prevalence of anti- Toxoplasma gondii antibodies in Turkish blood donors. Ethiop Med 2006; 44: 257–261.
  • 21. Güleşçi E, Otkun MT. Investigation of anti- Toxoplasma antibodies in patients with hematological malignancy. Türkiye Parazitol Derg 29(2): 85–88, 2005
  • 22. Alim M, Özçelik S, Özpınar N. Seroprevalence of Toxoplasma gondii in patients receiving cancer treatment. Cumhur Med J 2018, 40: 731–736.
  • 23. Yazar S, Yaman O, Eser B, et al. Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. J Med Microbiol 2004, 53: 1183–1186.
APA YILDIZ S, ESEN R, karaman k, Beyhan Y (2023). Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. , 291 - 295. 10.5505/ejm.2023.76743
Chicago YILDIZ SAADET,ESEN RAMAZAN,karaman kamuran,Beyhan Yunus Emre Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. (2023): 291 - 295. 10.5505/ejm.2023.76743
MLA YILDIZ SAADET,ESEN RAMAZAN,karaman kamuran,Beyhan Yunus Emre Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. , 2023, ss.291 - 295. 10.5505/ejm.2023.76743
AMA YILDIZ S,ESEN R,karaman k,Beyhan Y Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. . 2023; 291 - 295. 10.5505/ejm.2023.76743
Vancouver YILDIZ S,ESEN R,karaman k,Beyhan Y Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. . 2023; 291 - 295. 10.5505/ejm.2023.76743
IEEE YILDIZ S,ESEN R,karaman k,Beyhan Y "Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity." , ss.291 - 295, 2023. 10.5505/ejm.2023.76743
ISNAD YILDIZ, SAADET vd. "Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity". (2023), 291-295. https://doi.org/10.5505/ejm.2023.76743
APA YILDIZ S, ESEN R, karaman k, Beyhan Y (2023). Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. Eastern Journal of Medicine, 28(2), 291 - 295. 10.5505/ejm.2023.76743
Chicago YILDIZ SAADET,ESEN RAMAZAN,karaman kamuran,Beyhan Yunus Emre Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. Eastern Journal of Medicine 28, no.2 (2023): 291 - 295. 10.5505/ejm.2023.76743
MLA YILDIZ SAADET,ESEN RAMAZAN,karaman kamuran,Beyhan Yunus Emre Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. Eastern Journal of Medicine, vol.28, no.2, 2023, ss.291 - 295. 10.5505/ejm.2023.76743
AMA YILDIZ S,ESEN R,karaman k,Beyhan Y Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. Eastern Journal of Medicine. 2023; 28(2): 291 - 295. 10.5505/ejm.2023.76743
Vancouver YILDIZ S,ESEN R,karaman k,Beyhan Y Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity. Eastern Journal of Medicine. 2023; 28(2): 291 - 295. 10.5505/ejm.2023.76743
IEEE YILDIZ S,ESEN R,karaman k,Beyhan Y "Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity." Eastern Journal of Medicine, 28, ss.291 - 295, 2023. 10.5505/ejm.2023.76743
ISNAD YILDIZ, SAADET vd. "Seropositivity of Toxoplasma Gondii Among Blood Donors and Patients with Hematologic Malignity". Eastern Journal of Medicine 28/2 (2023), 291-295. https://doi.org/10.5505/ejm.2023.76743